The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Neuropeptide Y-2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats

Author

  • KA Gradin
  • CL Buus
  • Jia-Yi Li
  • O Frobert
  • U Simonsen

Summary, in English

1 The present study addressed the role of neuropeptide (NPY) Y-2 receptors in neurogenic contraction of mesenteric resistance arteries from female spontaneously hypertensive rats (SHR). Arteries were suspended in microvascular myographs, electrical field stimulation (EFS) was performed, and protein evaluated by Western blotting and immunohistochemistry. 2 In vasopressin-activated endothelium-intact arteries, NPY and fragments with selectivity for Y-1 receptors, [Leu(31), Pro(34)] NPY, Y-2 receptors, NPY(13-36), and rat pancreatic polypeptide evoked more pronounced contractions in segments from SHR than in Wistar Kyoto (WKY) arteries, even in the presence of the Y-1 receptor antagonist, BIBP3226 (0.3 mu M, (R)-N(2)-(diphenacetyl)-N-[(4-hydroxyphenyl) methyl]D-arginineamide). 3 In the presence of prazosin and during vasopressin activation, EFS-evoked contractions were larger in arteries from SHR compared to WKY. EFS contractions were enhanced by the Y2 receptor selective antagonist BIIE0246TF (0.5 mu M, (S)-N2-[[1-[2-[4-[(R, S)-5,11-dihydro-6(6h)-oxodibenz[b,e] azepin-11-y1]-1-piperazinyl]-2-oxoethyl]cyclo-pentyl-N-[2-[1,2-dihydro-3 ,5 (4H)-dioxo-1,2-diphenyl-3H- 1,2,4-triazol-4-yl] ethyl]- argininamide), reduced by BIBP3226, and abolished by the combination of BIBP3226 and BIIE0246TF. 4 Immunoblotting showed NPY Y-1 and Y-2 receptor expression to be similar in arteries from WKY and SHR, although a specific Y-2 receptor band at 80 kDa was detected only in arteries from WKY. 5 Immunoreaction for NPY was enhanced in arteries from SHR. In contrast to arteries from WKY, BIIE0246TF increased NPY immunoreactivity in EFS-stimulated arteries from SHR. 6 The present results suggest that postjunctional neuropeptide Y-1 and Y-2 receptors contribute to neurogenic contraction of mesenteric small arteries. Moreover, both enhanced NPY content and altered neuropeptide Y-1 and Y-2 receptor activation apparently contribute to the enhanced neurogenic contraction of arteries from SHR.

Publishing year

2006

Language

English

Pages

703-713

Publication/Series

British Journal of Pharmacology

Volume

148

Issue

5

Document type

Journal article

Publisher

Wiley

Topic

  • Pharmacology and Toxicology

Keywords

  • Wistar Kyoto rat
  • neuropeptide Y ( NPY)
  • receptors
  • hypertensive rat
  • spontaneously
  • mesenteric small arteries
  • BII0246TF
  • hypertension

Status

Published

ISBN/ISSN/Other

  • ISSN: 1476-5381